Literature DB >> 16463402

Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.

Yoshiaki Norimatsu1, Keiko Shimizu, Tadao K Kobayashi, Takuya Moriya, Choutatsu Tsukayama, Yasuyuki Miyake, Eiji Ohno.   

Abstract

BACKGROUND: Because cellular atypia is often limited in endometrial hyperplasia and well-differentiated endometrial adenocarcinoma (WHO Grade 1 adenocarcinoma), diagnostic criteria for endometrial cytology have not been fully established. New diagnostic criteria based on the composition and architecture of tissue fragments (cytoarchitecture) in the smears were used in the present study. Cytologic features are of less importance because the distinction between endometrial hyperplasia and Grade 1 adenocarcinoma relies more on architectural features than cellular changes. Cell clumps of various size are usually collected abundantly with cytologic material using a disposable scraping device and it was noticed that those cell clumps reflected the histologic architecture. The purpose of the current study was to determine the form of the cytoarchitecture that reflects the histologic structure and to examine the cellular features in endometrial hyperplasia and Grade 1 adenocarcinoma.
METHODS: The frequency of each type of cell clump (tube or sheet-shaped pattern, dilated or branched pattern, irregular protrusion, and papillotubular pattern) were obtained from 49 cases of normal proliferative endometrium (NPE) (patient age range, 28-51 yrs; average age, 39.9 yrs), 63 cases of endometrial hyperplasia without atypia (EH) (patient age range, 35-65 yrs; average age, 47.7 yrs), 13 cases of endometrial hyperplasia with atypia (AEH) (patient age range 47-65 yrs; average age, 53.8 yrs), and 49 cases of Grade 1 adenocarcinoma (patient age range, 42-73 yrs; average age, 58.9 yrs).
RESULTS: Certain characteristics of the cytoarchitecture were observed. In the NPE, cell clumps with a tube or sheet-shaped pattern were found in 97.5% of cases. In the EH, cell clumps with a dilated or branched pattern were found in 34.9% of cases. In the Grade 1 adenocarcinoma, cell clumps with irregular protrusions were found in 61.8% cases, whereas a papillotubular pattern was present in 29.7% of cases.
CONCLUSIONS: The results of the current study revealed that cytoarchitectural criteria appear to be more useful for the cytologic assessment of endometrial lesions, especially for the diagnosis of endometrial hyperplasia and Grade 1 adenocarcinoma. Copyright 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 16463402     DOI: 10.1002/cncr.21734

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Clinically Applicable Pathological Diagnosis System for Cell Clumps in Endometrial Cancer Screening via Deep Convolutional Neural Networks.

Authors:  Qing Li; Ruijie Wang; Zhonglin Xie; Lanbo Zhao; Yiran Wang; Chao Sun; Lu Han; Yu Liu; Huilian Hou; Chen Liu; Guanjun Zhang; Guizhi Shi; Dexing Zhong; Qiling Li
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

2.  New diagnostic reporting format for endometrial cytology based on cytoarchitectural criteria.

Authors:  K Yanoh; Y Norimatsu; Y Hirai; N Takeshima; A Kamimori; Y Nakamura; K Shimizu; T K Kobayashi; T Murata; T Shiraishi
Journal:  Cytopathology       Date:  2008-07-24       Impact factor: 2.073

3.  Diagnostic Utility of Endometrial Aspiration Cytology in Women with Abnormal Uterine Bleeding.

Authors:  Uma Handa; Chakshu Bansal; Phiza Aggarwal; Anju Huria; Harsh Mohan
Journal:  J Midlife Health       Date:  2018 Jul-Sep

4.  Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.

Authors:  Toshiaki Akahane; Ikumi Kitazono; Shintaro Yanazume; Masaki Kamio; Shinichi Togami; Ippei Sakamoto; Sachio Nohara; Seiya Yokoyama; Hiroaki Kobayashi; Tsubasa Hiraki; Shinsuke Suzuki; Shinichi Ueno; Akihide Tanimoto
Journal:  BMC Med Genomics       Date:  2020-07-11       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.